Experiment 478843

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationSEIDMAN,AD: NORTON,L: REICHMAN,BS: CROWN,JPA: YAO,TJ: HEELAN,R: HAKES,TB: LEBWOHL,DE: GILEWSKI,TA: SURBONE,A: CURRIE,V: HUDIS,CA: KLECKER,R: JAMIS-DOW:. (1993). PRELIMINARY EXPERIENCE WITH PACLITAXEL (TAXOL) PLUS RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN THE TREATMENT OF BREAST CANCER.. 20(4)
Amount utilized
Compound isolated
DiseasePACLITAXEL WAS ADMINISTERED TO PATIENTS WITH STAGE IV BREAST CANCER. ROUTINE USE OF GRANULOCYTE COLONY-STIMULATING FACTOR HELPED TO AMELIORATE NEUTROPENIA. PACLITAXEL WAS MORE ACTIVE IN PATIENTS NOT YET EXPOSED TO CHEMOTHERAPY, BUT ACTIVITY WAS SEEN IN PATIENTS PREVIOUSLY TREATED AS WELL.
Dose amount250.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M
Dose expressionDOSE
GenderFEMALE